Authors: | Yu, Qing-Jiang Liang, Yi-Zhi Mei, Xiao-Ping Fang, Tai-Yong |
Title: | Tumor mutation burden associated with miRNA-gene interaction outcome mediates the survival of patients with liver hepatocellular carcinoma |
Language (ISO): | en |
Abstract: | Tumor mutation burden (TMB) is associated with immunogenic responses and the survival of cancer patients. This study demonstrates how TMB levels impact the immune-related cells, genes, and miRNAs, and how miRNA/gene interactions respond to variations in the survival rate of patients with liver hepatocellular carcinoma (LIHC). LIHC patients were divided into two groups, either a low TMB (< median) or a high TMB (≥ median) group. We found that high TMB plays a positive role in immune-mediated infiltration, generating more CD4 T-cells and memory B cells. Among the 21 immune genes that altered significantly, only C9orf24 and CYP1A1 were expected to up-regulate in LIHC patients with high TMB. A total of 19 miRNAs, which regulate various functional pathways, were significantly altered in patients with LIHC. One of the miRNA/gene pair, hsa-miR-33a/ALDH1A3 was significantly associated with the survival rate of LIHC patients. Our results suggest that LIHC patients with high TMB can be treated more effectively with immunotherapy. |
Subject Headings: | Tumor mutation burden (TMB) miRNA-gene interaction Liver hepatocellular carcinoma (LIHC) Prognosis |
URI: | http://hdl.handle.net/2003/39856 http://dx.doi.org/10.17877/DE290R-21747 |
Issue Date: | 2020-06-22 |
Provenance: | IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund |
Citation: | https://www.excli.de/index.php/excli/article/view/2171 |
Appears in Collections: | Original Articles 2020 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
excli2020-2171.pdf | DNB | 857.09 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is protected by original copyright rightsstatements.org